Press Release|

Meet SHL at Pharmapack Europe 2020


SHL will exhibit at Pharmapack Europe 2020 between February 5-6 in Paris, France. In addition to showcasing our key services and products, Business Development Director Markus Bauss will give a talk in the Connectivity and Patient-Centricity conference session on February 5.

The talk, “Advancing Drug Delivery – Building the Business Case and Creating the Ecosystem for Intelligent Primary Containers,” will address various trends in digital industrialization and how the usage of smart technology in drug device production spans new possibilities in the pharmaceutical packaging space.

Key displays this year include the Needle Isolation Technology (NIT®), a pre-installed needle mechanism built to eliminate manual attachment for users of cartridge-based autoinjectors, and the second generation of the pre-configured Molly® autoinjector, built for high-volume manufacturing. Experts will also be on site to detail SHL’s final assembly and packaging services.

Visitors are welcomed to connect with our experts at stand C64 and learn about our vast array of product offerings and services.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News